Nabil Sumrani

1.8k total citations
89 papers, 1.5k citations indexed

About

Nabil Sumrani is a scholar working on Transplantation, Surgery and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Nabil Sumrani has authored 89 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Transplantation, 43 papers in Surgery and 21 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Nabil Sumrani's work include Renal Transplantation Outcomes and Treatments (61 papers), Organ Transplantation Techniques and Outcomes (32 papers) and Organ Donation and Transplantation (20 papers). Nabil Sumrani is often cited by papers focused on Renal Transplantation Outcomes and Treatments (61 papers), Organ Transplantation Techniques and Outcomes (32 papers) and Organ Donation and Transplantation (20 papers). Nabil Sumrani collaborates with scholars based in United States, Russia and Lebanon. Nabil Sumrani's co-authors include Joon H. Hong, Bruce G. Sommer, P. Daskalakis, Eli A. Friedman, Mariana Markell, Vera Delaney, Khalid M.H. Butt, Anne Marie V. Miles, Dale A. Distant and Robert P. Davis and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes Care and Journal of the American Society of Nephrology.

In The Last Decade

Nabil Sumrani

86 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nabil Sumrani United States 21 1.0k 674 356 246 242 89 1.5k
Bruce G. Sommer United States 21 742 0.7× 615 0.9× 264 0.7× 186 0.8× 186 0.8× 64 1.3k
A B Leichtman United States 9 1.0k 1.0× 638 0.9× 348 1.0× 290 1.2× 297 1.2× 13 1.4k
Dale A. Distant United States 16 825 0.8× 615 0.9× 410 1.2× 188 0.8× 128 0.5× 37 1.2k
Martin L. Milgrom United States 24 797 0.8× 1.1k 1.7× 380 1.1× 234 1.0× 113 0.5× 75 1.8k
Arthur J. Matas United States 15 730 0.7× 752 1.1× 355 1.0× 199 0.8× 80 0.3× 30 1.1k
Joon H. Hong United States 19 545 0.5× 471 0.7× 227 0.6× 405 1.6× 117 0.5× 47 1.1k
R. Palomar Spain 17 594 0.6× 406 0.6× 153 0.4× 159 0.6× 96 0.4× 49 1.1k
Marcelo Santos Sampaio United States 19 667 0.7× 619 0.9× 165 0.5× 145 0.6× 109 0.5× 36 1.3k
Kunam S. Reddy United States 27 1.4k 1.4× 1.4k 2.1× 771 2.2× 419 1.7× 145 0.6× 115 2.2k
Gilbert Ross United States 19 382 0.4× 535 0.8× 196 0.6× 268 1.1× 122 0.5× 88 1.1k

Countries citing papers authored by Nabil Sumrani

Since Specialization
Citations

This map shows the geographic impact of Nabil Sumrani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nabil Sumrani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nabil Sumrani more than expected).

Fields of papers citing papers by Nabil Sumrani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nabil Sumrani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nabil Sumrani. The network helps show where Nabil Sumrani may publish in the future.

Co-authorship network of co-authors of Nabil Sumrani

This figure shows the co-authorship network connecting the top 25 collaborators of Nabil Sumrani. A scholar is included among the top collaborators of Nabil Sumrani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nabil Sumrani. Nabil Sumrani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chen, Yixin, et al.. (2020). COVID‐19 pneumonia in kidney transplant recipients: Focus on immunosuppression management. Transplant Infectious Disease. 22(5). e13378–e13378. 29 indexed citations
3.
Markell, Mariana, Dimitre G. Stefanov, Rahul M. Jindal, et al.. (2017). Mortality after Renal Allograft Failure and Return to Dialysis. American Journal of Nephrology. 45(2). 180–186. 38 indexed citations
4.
Stefanov, Dimitre G., Rahul M. Jindal, Devon John, et al.. (2016). Mortality on the Kidney Waiting List and After Transplantation in Patients With Peripheral Arterial Disease: An Analysis of the United States Renal Data System. Transplantation Proceedings. 48(1). 15–20. 8 indexed citations
5.
Jindal, Rahul M., Eric A. Elster, Fasika Tedla, et al.. (2013). Effect of Peripheral Vascular Disease on Kidney Allograft Outcomes. Transplantation. 95(6). 810–815. 29 indexed citations
6.
Bhagavati, Satyakam, et al.. (2007). Chronic Sensorimotor Polyneuropathy Associated With Tacrolimus Immunosuppression in Renal Transplant Patients: Case Reports. Transplantation Proceedings. 39(10). 3465–3467. 24 indexed citations
7.
Homel, Peter, Nabil Sumrani, JinWoo Hong, et al.. (1998). Effect of variability of cyclosporine pharmacokinetics on long-term renal allograft survival. Transplantation Proceedings. 30(5). 1980–1982. 3 indexed citations
8.
Sumrani, Nabil, Anne Marie V. Miles, Dale A. Distant, et al.. (1997). Survival on hemodialysis versus renal transplantation following primary renal allograft failure. Transplantation Proceedings. 29(8). 3602–3604. 8 indexed citations
9.
Ifudu, Onyekachi, Peter Homel, Joon H. Hong, et al.. (1997). Determinants of Type of Initial Hemodialysis Vascular Access. American Journal of Nephrology. 17(5). 425–427. 24 indexed citations
10.
Miles, Anne Marie V., Mariana Markell, P. Daskalakis, et al.. (1997). Anemia following renal transplantation: erythropoietin response and iron deficiency. Clinical Transplantation. 11(4). 313–315. 50 indexed citations
11.
Sumrani, Nabil, Thomas V. Cacciarelli, P. Daskalakis, et al.. (1993). Contribution of acute rejection to renal allograft loss from chronic rejection.. PubMed. 25(3). 2259–60. 8 indexed citations
12.
Sumrani, Nabil, Anne Marie V. Miles, Vera Delaney, et al.. (1992). Renal transplantation in cyclosporine-treated patients with end-stage lupus nephropathy.. PubMed. 24(5). 1785–7. 17 indexed citations
13.
Sumrani, Nabil, et al.. (1992). The influence of cold ischemia and donor age on renal allograft outcome in the cyclosporine era.. PubMed. 24(5). 2044–5. 6 indexed citations
14.
Sumrani, Nabil, Veronica Delaney, Robert P. Davis, et al.. (1991). Posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients.. PubMed. 23(1 Pt 2). 1249–50. 28 indexed citations
15.
Sumrani, Nabil, et al.. (1991). Effect of timing of cyclosporine administration on recovery from renal ischemia in rats. Journal of Surgical Research. 51(4). 341–343. 3 indexed citations
16.
Sumrani, Nabil, Vera Delaney, Robert P. Davis, et al.. (1991). RENAL TRANSPLANTATION FROM ELDERLY LIVING DONORS. Transplantation. 51(2). 305–308. 42 indexed citations
17.
Sumrani, Nabil, et al.. (1991). Prolonged Simple Cryothermic Immersion Storage of Rat Heart Isografts: A Preliminary Study. Journal of Investigative Surgery. 4(2). 171–174. 1 indexed citations
18.
Emre, S, Nabil Sumrani, & Jang Hee Hong. (1990). Beneficial Effect of Thalidomide and Ciclosporin Combination in Heterotopic Cardiac Transplantation in Rats. European Surgical Research. 22(6). 336–339. 8 indexed citations
19.
Sumrani, Nabil, et al.. (1989). Renal allotransplantation following repair of an aneurysm of the donor renal artery.. PubMed. 302–302. 1 indexed citations
20.
Sumrani, Nabil, et al.. (1989). Complications of "one stitch" extravesical ureteric implantation in renal transplants in the cyclosporine and precyclosporine eras.. PubMed. 21(1 Pt 2). 1957–9. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026